Zobrazeno 1 - 10
of 197
pro vyhledávání: '"Michael Back"'
Autor:
Nathaniel Barry, Eng-Siew Koh, Martin A. Ebert, Alisha Moore, Roslyn J. Francis, Pejman Rowshanfarzad, Ghulam Mubashar Hassan, Sweet P. Ng, Michael Back, Benjamin Chua, Mark B. Pinkham, Andrew Pullar, Claire Phillips, Joseph Sia, Peter Gorayski, Hien Le, Suki Gill, Jeremy Croker, Nicholas Bucknell, Catherine Bettington, Farhan Syed, Kylie Jung, Joe Chang, Andrej Bece, Catherine Clark, Mori Wada, Olivia Cook, Angela Whitehead, Alana Rossi, Andrew Grose, Andrew M. Scott
Publikováno v:
Physics and Imaging in Radiation Oncology, Vol 30, Iss , Pp 100568- (2024)
Background and purpose: The [18]F-fluoroethyl-l-tyrosine (FET) PET in Glioblastoma (FIG) study is an Australian prospective, multi-centre trial evaluating FET PET for newly diagnosed glioblastoma management. The Radiation Oncology credentialing progr
Externí odkaz:
https://doaj.org/article/63aa463857ac487a8aa4e65fec51d503
Autor:
Eric Wegener, Patrick Horsley, Helen Wheeler, Dasantha Jayamanne, Marina Kastelan, Linxin Guo, Chris Brown, Michael Back
Publikováno v:
BMC Neurology, Vol 23, Iss 1, Pp 1-10 (2023)
Abstract Background Spinal neuraxis leptomeningeal metastasis (LM) relapse in glioblastoma is an uncommon event that is challenging to manage. This study aims to determine the incidence, associated factors, and outcome of LM relapse in patients with
Externí odkaz:
https://doaj.org/article/82655ecc127a424088c07abe6035dcac
Autor:
Alexander Yuile, Laveniya Satgunaseelan, Joe Q. Wei, Michael Rodriguez, Michael Back, Nick Pavlakis, Amanda Hudson, Marina Kastelan, Helen R. Wheeler, Adrian Lee
Publikováno v:
Current Issues in Molecular Biology, Vol 45, Iss 7, Pp 5276-5292 (2023)
Genomic alterations of CDKN2A and CDKN2B in astrocytomas have been an evolving area of study for decades. Most recently, there has been considerable interest in the effect of CDKN2A and/or CDKN2B (CDKN2A/B) homozygous deletions (HD) on the prognosis
Externí odkaz:
https://doaj.org/article/cd5e480404154d849fb4a23f59390562
Autor:
Caterina Brighi, David E. J. Waddington, Paul J. Keall, Jeremy Booth, Kieran O’Brien, Shona Silvester, Jonathon Parkinson, Marco Mueller, Jackie Yim, Dale L. Bailey, Michael Back, James Drummond
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
BackgroundGlioblastoma (GBM) is the most aggressive type of brain cancer, with a 5-year survival rate of ~5% and most tumours recurring locally within months of first-line treatment. Hypoxia is associated with worse clinical outcomes in GBM, as it le
Externí odkaz:
https://doaj.org/article/5edcdad8f4af4d379976474a7c4ef04a
Autor:
Eng-Siew Koh, Mustafa Khasraw, Elizabeth H Barnes, Kyle M Walsh, Mark Rosenthal, Rodney J Hicks, Farshad Foroudi, Hui K Gan, Anna K Nowak, Dale L Bailey, Paul Roach, Arian Lasocki, Robyn Leonard, Roel Verhaak, Andrew M Scott, Alisha Moore, Bradford A Moffat, Clare Senko, Roslyn J Francis, Martin Ebert, Sze Ting Lee, Eddie Lau, Greg Fitt, Robert Coffey, Richard De Abreu Lourenco, Lucas Adda, Paul A Thomas, Michael Back
Publikováno v:
BMJ Open, Vol 13, Iss 8 (2023)
Introduction Glioblastoma is the most common aggressive primary central nervous system cancer in adults characterised by uniformly poor survival. Despite maximal safe resection and postoperative radiotherapy with concurrent and adjuvant temozolomide-
Externí odkaz:
https://doaj.org/article/d8d21057c5584e9388379c1d9d0c188d
Publikováno v:
Brain Sciences, Vol 13, Iss 11, p 1579 (2023)
Purpose: Patients with glioblastoma (GBM) may demonstrate varying patterns of infiltration and relapse. Improving the ability to predict these patterns may influence the management strategies at the time of initial diagnosis. This study aims to exami
Externí odkaz:
https://doaj.org/article/3af928e27c084e0884e665364b0d5013
Autor:
Gabrielle Metz, Dasantha Jayamanne, Helen Wheeler, Matthew Wong, Raymond Cook, Nicholas Little, Jonathon Parkinson, Marina Kastelan, Chris Brown, Michael Back
Publikováno v:
BMC Neurology, Vol 22, Iss 1, Pp 1-13 (2022)
Abstract Background The impact of near-total resection of IDH-mutated anaplastic glioma (IDHmutAG) is well-established but there remains uncertainty of benefit in tumours of the insular cortex where the extent of safe resection may be limited. This s
Externí odkaz:
https://doaj.org/article/fe1858d14cb6494aa4c2d7cc6f25c882
Autor:
James O’Toole, Maddison Picton, Mario Perez, Michael Back, Dasantha Jayamanne, Andrew Le, Kenny Wu, Chris Brown, John Atyeo
Publikováno v:
Journal of Medical Radiation Sciences, Vol 68, Iss 4, Pp 364-370 (2021)
Abstract Introduction This study aimed to develop a single‐isocentre volumetric modulated arc therapy (si‐VMAT) technique for multiple brain metastases using knowledge‐based planning software, comparing it with a multiple‐isocentre stereotact
Externí odkaz:
https://doaj.org/article/354edc3040304c838f575575c8a1c0c8
Autor:
Joseph Chan, Dasantha Jayamanne, Helen Wheeler, Mustafa Khasraw, Matthew Wong, Marina Kastelan, Lesley Guo, Michael Back
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 22, Iss , Pp 33-39 (2020)
Background and purpose: Current practice in re-irradiation (reRT) of previously treated high-grade gliomas (HGG) has generally been limited to small volume reRT with stereotactic procedures. Less evidence exists for large volume reRT involving treatm
Externí odkaz:
https://doaj.org/article/7ef9a03f23e5418abca86fcb8e0d619b
Autor:
Byeongsang Oh, Frances Boyle, Nick Pavlakis, Stephen Clarke, Alex Guminski, Thomas Eade, Gillian Lamoury, Susan Carroll, Marita Morgia, Andrew Kneebone, George Hruby, Mark Stevens, Wen Liu, Brian Corless, Mark Molloy, Towia Libermann, David Rosenthal, Michael Back
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Increasing evidence suggests that the gut microbiome is associated with both cancer chemotherapy (CTX) outcomes and adverse events (AEs). This review examines the relationship between the gut microbiome and CTX as well as the impact of CTX on the gut
Externí odkaz:
https://doaj.org/article/55fe88a7821b4413912e926930a2d51c